EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act EAE

Friday, 18. October 2019 17:01
--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc with the aim of a
  Europe-wide distribution. The issuer is responsible for the content of this
  announcement.
--------------------------------------------------------------------------------

Overview
1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Acquisition or disposal of voting rights
3. Person subject to notification obligation
Name: Privatstiftung für die Standorterhaltung in Oberösterreich
City: Linz
Country: Österreich
4. Name of shareholder(s): Invest Unternehmensbeteiligungs Aktiengesellschaft
5. Date on which the threshold was crossed or reached: 18.10.2019
6. Total positions

 ______________________________________________________________________________
|               |               |  % of voting  |              |               |
|               |  % of voting  |rights through |Total of both |Total number of|
|               |rights attached|financial/other| in % (7.A +  | voting rights |
|               |to shares (7.A)| instruments   |     7.B)     |   of issuer   |
|               |               |(7.B.1 + 7.B.2)|              |               |
|_______________|_______________|_______________|______________|_______________|
|   Resulting   |               |               |              |               |
| situation on  |               |               |              |               |
|  the date on  |               |               |              |               |
|which threshold|    3.24 %     |    0.00 %     |    3.24 %    |   1 469 772   |
| was crossed / |               |               |              |               |
|    reached    |               |               |              |               |
|_______________|_______________|_______________|______________|_______________|
|  Position of  |               |               |              |               |
|   previous    |               |               |              |               |
| notification  |    8.70 %     |               |    8.70 %    |               |
|(if applicable)|               |               |              |               |
|_______________|_______________|_______________|______________|_______________|


Details
7. Notified details of the resulting situation:

 ______________________________________________________________________________
|A: Voting rights attached to shares                                           |
|______________________________________________________________________________|
|             |    Number of voting rights    |       % of voting rights       |
|             |_______________________________|________________________________|
|             |    Direct     |   Indirect    |    Direct     |    Indirect    |
|  ISIN Code  |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 BörseG |
|             |     2018)     |     2018)     |     2018)     |     2018)      |
|_____________|_______________|_______________|_______________|________________|
|ATMARINOMED6 |               |         47 587|               |          3.24 %|
|_____________|_______________|_______________|_______________|________________|
| SUBTOTAL A  |            47 587             |             3.24 %             |
|_____________|_______________________________|________________________________|


 ______________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG  |
|2018                                                                          |
|______________________________________________________________________________|
|             |               |               |Number of voting |              |
|             |               |               | rights that may |              |
|             |               |               |       be        |              |
|   Type of   |Expiration Date|Exercise Period|acquired if the  | % of voting  |
| instrument  |               |               |  instrument is  |    rights    |
|             |               |               |    exercised    |              |
|_____________|_______________|_______________|_________________|______________|
|_____________|_______________|_______________|_________________|______________|
|             |               | SUBTOTAL B.1  |                 |              |
|_____________|_______________|_______________|_________________|______________|


 _____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
|2018                                                                         |
|_____________________________________________________________________________|
|           |            |           | Physical /  | Number of   |            |
|  Type of  | Expiration | Exercise  |    Cash     |voting rights|% of voting |
|instrument |    Date    |  Period   | Settlement  |             |   rights   |
|___________|____________|___________|_____________|_____________|____________|
|___________|____________|___________|_____________|_____________|____________|
|           |            |           |SUBTOTAL B.2 |             |            |
|___________|____________|___________|_____________|_____________|____________|


8. Information in relation to the person subject to the notification obligation:
Full chain of controlled undertakings through which the voting rights and/or the
financial/other instruments are effectively held starting with the ultimate
controlling natural person or legal entity:

 ____________________________________________________________________________
|      |                        |          |          |Financial/ |          |
|      |                        |          |  Shares  |   other   |          |
|      |                        | Directly |   held   |instruments| Total of |
| No.  |          Name          |controlled|directly  |   held    | both (%) |
|      |                        |  by No.  |   (%)    | directly  |          |
|      |                        |          |          |    (%)    |          |
|______|________________________|__________|__________|___________|__________|
|      |Privatstiftung für die  |          |          |           |          |
|  1   |Standorterhaltung in    |          |          |           |          |
|      |Oberösterreich          |          |          |           |          |
|______|________________________|__________|__________|___________|__________|
|  2   |IAG Beteiligungen GmbH  |    1     |          |           |          |
|______|________________________|__________|__________|___________|__________|
|      |Invest                  |          |          |           |          |
|  3   |Unternehmensbeteiligungs|    2     |    3.24 %|           |    3.24 %|
|      |Aktiengesellschaft      |          |          |           |          |
|______|________________________|__________|__________|___________|__________|


9. In case of proxy voting
Date of general meeting: -
Voting rights after general meeting: - is equivalent to - voting rights.

10. Additional comments:
-

Further inquiry note:

Dr. Eva Prieschl-Grassauer
Chief Scientific Officer, Marinomed
Veterinärplatz 1, 1210 Vienna, Austria
T +43 (0)1 250 77 4460
E-Mail: eva.prieschl@marinomed.com
http://www.marinomed.com

Roland Mayrl
Managing Partner, Metrum Communications
Bauernmarkt 10/19, 1010 Vienna, Austria
T +43 (0) 1 504 69 87 331
E-Mail: r.mayrl@metrum.at
http://www.metrum.at

end of announcement                         euro adhoc
--------------------------------------------------------------------------------

issuer:       Marinomed Biotech AG
              Veterinärplatz 1
              A-1210 Wien
phone:        0043250774460
FAX:          0043250774493
mail:         office@marinomed.com
WWW:          www.marinomed.com
ISIN:         ATMARINOMED6, AT0000A1WD52
indexes:      
stockmarkets: Wien
language:     English

EAX0015    2019-10-18/17:01

Related Links: Marinomed Biotech AG
Author:
Ad-hoc-Mitteilung übermittelt durch euro adhoc.
Für den Inhalt ist der Emittent verantwortlich.